A Double-Blind, Randomized, Multi-Center Study Followed By 12 Months Open-Label Treatment To Evaluate The Dose Response And Safety Of Valsartan In Pediatric Hypertension Patients 1 – 5 Years Of Age.
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Hydrochlorothiazide; Valsartan
- Indications Hypertension
- Focus Therapeutic Use
- 07 Nov 2011 Actual end date (November 2006) added as reported by ClinicalTrials.gov.
- 01 Aug 2008 Results published in Hypertension.
- 30 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History